Clinical Pharmacokinetics

Wolters Kluwer Health Logo

Login
Register
Help

Advanced Search
Saved Searches
Recent Searches

You currently have no recent searches

Home	AdisOnline Home	Current Issue	Previous Issues	Published Ahead-of-Print	Collections	Services	Information

Article Collections

Subscribe

Subscribe to eAlerts

For Librarians

RSS Feeds

Rights & Permissions

Reprints & ePrints

Supplements

Sponsored Subscriptions

About the Journal

Editorial Board

Submit a Manuscript

Journal Policies

Reviewers Information

Supplement Policies

Home > March 01, 2008 - Volume 47 - Issue 3

< Previous Issue | Next Issue >

March 01, 2008 - Volume 47 - Issue 3

pp: 147-216

Table of Contents Outline

Download TOC to PDA

View Contributor Index

Add Item(s) to:

An Existing Folder

A New Folder

Folder Name:

Description:

The item(s) has been successfully added to "".

Email to a Colleague

Colleague's E-mail is Invalid

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw in Clinical Pharmacokinetics.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

Export to.

End Note
Procite
Reference Manager

Save my selection

Select All | Hide Details

Current Opinion

Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?

Pea, Federico; Viale, Pierluigi

Clinical Pharmacokinetics. 47(3):147-152, March 01, 2008.

Purchase Access

PDF (237 KB)

Abstract:

Table of Contents Outline | Back to Top

Review Article

Antiretroviral Therapy: Pharmacokinetic Considerations in Patients with Renal or Hepatic Impairment

McCabe, Sarah M; Ma, Qing; Slish, Judianne C; Catanzaro, Linda M; Sheth, Neha; DiCenzo, Robert; Morse, Gene D

Clinical Pharmacokinetics. 47(3):153-172, March 01, 2008.

Purchase Access

PDF (308 KB)

Abstract:

Table of Contents Outline | Back to Top

Original Research Article

Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Isla, Arantxazu; Rodríguez-Gascón, Alicia; Trocóniz, Iñaki F; Bueno, Lorea; Solinís, María Ángeles; Maynar, Javier; Sánchez-Izquierdo, José Ángel; Pedraz, José Luis

Clinical Pharmacokinetics. 47(3):173-180, March 01, 2008.

Purchase Access

PDF (337 KB)

Abstract:

Application of Basic Pharmacokinetic Concepts to Analysis of Microdialysis Data: Illustration with Imipenem Muscle Distribution

Dahyot, Claire; Marchand, Sandrine; Bodin, Mikael; Debeane, Bertrand; Mimoz, Olivier; Couet, William

Clinical Pharmacokinetics. 47(3):181-189, March 01, 2008.

Purchase Access

PDF (309 KB)

Abstract:

In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

Lobo, Evelyn D; Bergstrom, Richard F; Reddy, Shobha; Quinlan, Tonya; Chappell, Jill; Hong, Quan; Ring, Barbara; Knadler, Mary Pat

Clinical Pharmacokinetics. 47(3):191-202, March 01, 2008.

Purchase Access

PDF (293 KB)

Abstract:

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - in Patients Undergoing Major Orthopaedic Surgery

Mueck, Wolfgang; Eriksson, Bengt I; Bauer, Kenneth A; Borris, Lars; Dahl, Ola E; Fisher, William D; Gent, Michael; Haas, Sylvia; Huisman, Menno V; Kakkar, Ajay K; Kälebo, Peter; Kwong, Louis M; Misselwitz, Frank; Turpie, Alexander G G

Clinical Pharmacokinetics. 47(3):203-216, March 01, 2008.

Purchase Access

PDF (1.13 MB)

Abstract:

Table of Contents Outline | Back to Top

Table of Contents Sections

Current Opinion
Review Article
Original Research Article

Select All

Copyright © 2009
All rights reserved.

Privacy Policy
Terms of Use
Public Access Policy
Contact Us

Adis is a partner of the following organizations: HINARI
Cross Ref
COUNTER